16 studies found for:
"transthyretin amyloidosis"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Unknown † |
Safety, Efficacy and Pharmacokinetics of Doxycycline Plus Tauroursodeoxycholic Acid in Transthyretin Amyloidosis
|
||||
| 2 | Recruiting |
Prevalence of Transthyretin Amyloidosis in Hypertrophic Cardiomyopathy
|
||||
| 3 | Not yet recruiting |
Tolerability and Efficacy of a Combination of Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy
|
||||
| 4 | Recruiting |
Efficacy and Safety of ISIS TTR Rx in Familial Amyloid Polyneuropathy
|
||||
| 5 |
Completed
Has Results |
An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy
|
||||
| 6 | Not yet recruiting |
Imaging Cardiac Amyloidosis: A Pilot Study Using F-18 Florbetapir and C-11 PiB Positron Emission Tomography
|
||||
| 7 | Recruiting |
The Effect Of Tafamidis For The Transthyretin Amyloid Polyneuropathy Patients With V30M Or Non-V30M Transthyretin
|
||||
| 8 | Recruiting |
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
|
||||
| 9 | Recruiting |
The Effect of Diflunisal on Familial Transthyretin Amyloidosis
|
||||
| 10 |
Completed
Has Results |
Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis
|
||||
| 11 | Completed |
The Effect of Diflunisal on Familial Amyloidosis
|
||||
| 12 | Active, not recruiting |
Safety And Efficacy Evaluation Of Fx-1006A In Subjects With Transthyretin Amyloidosis
|
||||
| 13 |
Completed
Has Results |
The Effects of Fx-1006A on Transthyretin Stabilization and Clinical Outcome Measures in Patients With Non-V30M Transthyretin Amyloidosis
|
||||
| 14 | Active, not recruiting |
Burden of Illness Study In Patients With Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) orTransthyretin Cardiomyopathy (TTR-CM) And Caregivers
|
||||
| 15 |
Completed
Has Results |
The Effects Of Fx-1006A On Transthyretin Stabilization And Clinical Outcome Measures In Patients With V122I Or Wild-Type TTR Amyloid Cardiomyopathy
|
||||
| 16 | Active, not recruiting |
Safety And Efficacy Evaluation Of Fx-1006a In Patients With V122i Or Wild-Type Transthyretin (TTR) Amyloid Cardiomyopathy
|
† Indicates status has not been verified in more than two years